Intravenous iron in inflammatory bowel disease

The prevalence of anemia across studies on patients with inflammatory bowel disease (IBD) is high (30%). Both iron deficiency (ID) and anemia of chronic disease contribute most to the development of anemia in IBD. The prevalence of ID is even higher (45%). Anemia and ID negatively impact the patient...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	World journal of gastroenterology : WJG 2009-10, Vol.15 (37), p.4666-4674
Hauptverfasser:	Muñoz, Manuel, Gómez-Ramírez, Susana, García-Erce, José Antonio
Format:	Artikel
Sprache:	eng
Schlagworte:	Ferric Compounds - administration & dosage Ferric Compounds - therapeutic use Ferric Oxide, Saccharated Glucaric Acid Gluconates - administration & dosage Gluconates - therapeutic use Humans Inflammatory Bowel Diseases - drug therapy Infusions, Intravenous Injections, Intraventricular Iron - administration & dosage Iron - adverse effects Iron - therapeutic use Iron-Dextran Complex - administration & dosage Iron-Dextran Complex - therapeutic use Maltose - administration & dosage Maltose - analogs & derivatives Maltose - therapeutic use Topic Highlight Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!